✦ LIBER ✦

Second-line treatment options in metastatic castration-resistant prostate cancer: A comparison of key trials with recently approved agents

✍ Scribed by Bahl, Amit; Masson, Susan; Birtle, Alison; Chowdhury, Simon; de Bono, Johann

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN17 NO CONCLUSIVE EVIDENCE FROM RANDOM

✍ M Mason; N Freemantle; A Parnaby; D Högberg 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

P119 Design of a randomized, open-label

✍ Beer, T.M.; Blumenstein, B.A.; Fizazi, K.; Hotte, S.J.; Jacobs, C.; Stewart, P.S 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Aflibercept versus placebo in combinatio

✍ Tannock, Ian F; Fizazi, Karim; Ivanov, Sergey; Karlsson, Camilla Thellenberg; Fl 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 310 KB

Re: Aflibercept versus Placebo in Combin

✍ Taneja, Samir S. 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 59 KB

565 POSTER Activity of the anti-IGF-IR a

✍ J.S. De Bono; D.P. Petrylak; E. Calvo; F. Saad; G.R. Hudes; M.M. Cooney; M.N. Po 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

A Comparison of the Analgesic Effect and

✍ Milecki, P.; Baczyk, M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB